210658 — Inebilizumab-cdon 10 Mg/ml Intravenous Solution
$143,084
All-payer median here
8
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.